Indication
Migraine
Migraine is a chronic neurovascular disorder of the central nervous system characterized by recurrent, disabling headache attacks that affect both pediatric and adult populations, with a pronounced female predominance. Read more about Migraine
305 drugs 161 manufacturers
Drugs that treat it
Common Migraine therapies.
MAXALT (rizatriptan benzoate)
SUMATRIPTAN
DICLOFENAC POTASSIUM
DIHYDROERGOTAMINE MESYLATE
SUMATRIPTAN
NARATRIPTAN HCL
SUMATRIPTAN SUCCINATE
HEADACHE RELIEF (aspirin/acetaminophen/caffeine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMigraine is a chronic neurovascular disorder of the central nervous system characterized by recurrent, disabling headache attacks that affect both pediatric and adult populations, with a pronounced female predominance.
Clinically, episodes typically manifest as moderate-to-severe, throbbing, unilateral head pain lasting 4 to 72 hours, exacerbated by physical routine and frequently accompanied by nausea, vomiting, photophobia, and phonophobia.
A subset of individuals experiences transient, reversible focal neurological disturbances known as auras, most commonly visual, which precede or accompany the cephalalgia.
Pathophysiologically, migraine is driven by altered brain sensory processing, cortical spreading depression, and activation of the trigeminovascular system, which triggers the perivascular release of vasoactive neuropeptides and neurogenic inflammation.
- medlineplus.gov
Migraine is a chronic neurovascular disorder of the central nervous system characterized by recurrent, disabling headache attacks that affect both pediatric and adult populations, with a pronounced female predominance
- nih.gov
Migraine is a chronic neurovascular disorder of the central nervous system characterized by recurrent, disabling headache attacks that affect both pediatric and adult populations, with a pronounced female predominance Clinically, episodes typically manifest as moderate-to-severe, throbbing, unilateral head pain lasting 4 to 72 hours, exacerbated by physical routine and frequently accompanied by nausea, vomiting, photophobia, and phonophobia
- nih.gov
Migraine is a chronic neurovascular disorder of the central nervous system characterized by recurrent, disabling headache attacks that affect both pediatric and adult populations, with a pronounced female predominance
- nih.gov
Clinically, episodes typically manifest as moderate-to-severe, throbbing, unilateral head pain lasting 4 to 72 hours, exacerbated by physical routine and frequently accompanied by nausea, vomiting, photophobia, and phonophobia A subset of individuals experiences transient, reversible focal neurological disturbances known as auras, most commonly visual, which precede or accompany the cephalalgia
- nih.gov
Clinically, episodes typically manifest as moderate-to-severe, throbbing, unilateral head pain lasting 4 to 72 hours, exacerbated by physical routine and frequently accompanied by nausea, vomiting, photophobia, and phonophobia Pathophysiologically, migraine is driven by altered brain sensory processing, cortical spreading depression, and activation of the trigeminovascular system, which triggers the perivascular release of vasoactive neuropeptides and neurogenic inflammation
- nih.gov
A subset of individuals experiences transient, reversible focal neurological disturbances known as auras, most commonly visual, which precede or accompany the cephalalgia Pathophysiologically, migraine is driven by altered brain sensory processing, cortical spreading depression, and activation of the trigeminovascular system, which triggers the perivascular release of vasoactive neuropeptides and neurogenic inflammation
- migrainedisorders.org
Pathophysiologically, migraine is driven by altered brain sensory processing, cortical spreading depression, and activation of the trigeminovascular system, which triggers the perivascular release of vasoactive neuropeptides and neurogenic inflammation
- nih.gov
Pathophysiologically, migraine is driven by altered brain sensory processing, cortical spreading depression, and activation of the trigeminovascular system, which triggers the perivascular release of vasoactive neuropeptides and neurogenic inflammation
Personalize your experience
Follow Migraine and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.